AccessibilityHelpAbout Us
Prenetics Global logo

Prenetics Global(NASDAQ) PRE

Market Cap$402.36MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-80%
5 Year-84%
1 Year+165%
1 Month+26%
Premium Feature
Moneyball Superscore
65/100
$23.43
-0.97%
-0.23Today
After hours$23.39-$0.04 (-0.17%)
Prenetics Global last closing stock price
MetricPriceDate
Last closeUSD 23.472026-09-11
Prenetics Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.74%USD 25.442026-09-04
1 month+25.64%USD 18.682026-08-12
3 month+8.51%USD 21.632026-06-12
Year to date+49.02%USD 15.752025-12-31
1 year+164.9%USD 8.862025-09-11
3 year+200.32%USD 7.822023-09-12
5 year-83.9%USD 145.802021-09-09
Since inception-79.88%USD 116.632021-07-16

Prenetics Global Financials at a Glance

Market Cap

$402.36MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$142.56M

Net Income (TTM)

-$67.61M

EPS (TTM)

-$4.17

P/E Ratio

-5.63

Dividend

$0.00

Beta (Volatility)

0.47 (Low)

Price

$23.43

Volume

143,971.388

Open

$23.78

Previous Close

$23.47

Daily Range

$22.95 - $23.90

52-Week Range

$9.28 - $27.24

Estimated Earnings Date

Nov 9, 2026

PRE News

DNA with icons and doctor

Why Prenetics Global Stock Is Skyrocketing Today

Keith SpeightsJan 10, 2023

PRE: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prenetics Global

Prenetics Global Limited is an investment holding company specializing in diagnostic and genetic testing services. The company offers a diverse range of products, including consumer-oriented genetic analysis and advanced health monitoring devices.

Products and Services
  • CircleDNA: A consumer genetic analysis solution
  • Circle HealthPod: Rapid COVID-19 detection device
  • ColoClear: Non-invasive colorectal cancer screening test
Growth Outlook
  • Revenue increased to $46.5 million in Q2 2026, up from $35.9 million in Q1 2026
  • Gross profit margin improved to 65% in Q2 2026
  • Strong cash position with $59 million in cash and short-term investments
Financial Highlights
  • Net income for Q2 2026 was a loss of $8.9 million
  • Operating expenses totaled $52.1 million in Q2 2026
  • Current ratio stands at 4.04, indicating strong liquidity
Prenetics Global Limited has established itself as a key player in the healthcare sector, focusing on innovative diagnostic solutions. The company's product offerings cater to a growing demand for genetic testing and health monitoring, positioning it well for future growth. Recent financial performance shows a notable increase in revenue, reflecting the effectiveness of its business strategies. Despite facing net losses, the company maintains a robust cash position, which may support ongoing operations and potential expansion initiatives. The strong liquidity ratio further underscores the company's ability to meet short-term obligations, making it an intriguing option for investors interested in the healthcare diagnostics market.
AI Generated • Aug 28, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

98

CEO

Sheng Wu Yeung

Website

www.prenetics.com

Headquarters

Hong Kong, HK

PRE Financials

Key Financial Metrics (TTM)

Gross Margin

62.61%

Operating Margin

-35.20%

Net Income Margin

-47.43%

Return on Equity

-49.17%

Return on Capital

-21.57%

Return on Assets

-44.00%

Earnings Yield

-17.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$402.36MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

17.14M

Volume

143.97K

Avg. Volume

221.49K

Financials (TTM)

Gross Profit

$89.25M

Operating Income

-$50.18M

EBITDA

-$62.52M

Operating Cash Flow

-$49.39M

Capital Expenditure

$15.25M

Free Cash Flow

-$34.14M

Cash & ST Invst.

$109.39M

Total Debt

$682.00K

Prenetics Global Performance Analysis

Prenetics Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 13,163,841-95.2%
20232023-12-31USD 21,742,67565.2%
20242024-12-31USD 15,936,000-26.7%
20252025-12-31USD 92,390,000479.8%
Prenetics Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3033.2%
Q42025-12-3155.2%
Q12026-03-31-1.7%
Q22026-06-3029.3%
Prenetics Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -37.57154.4%
20232023-12-31USD -5.58-85.2%
20242024-12-31USD -3.71-33.6%
20252025-12-31USD -2.68-27.6%
Prenetics Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3043.6%
Q42025-12-31-230.2%
Q12026-03-3122.3%
Q22026-06-3061.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$46.49M

+162.9%

Gross Profit

$30.20M

+314.4%

Gross Margin

64.97%

N/A

Market Cap

$402.36MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.11M

N/A

Employees

98

N/A

Net Income

-$8.98M

+27.6%

EBITDA

-$21.73M

-99.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$109.39M

+294.8%

Total Debt

$682.00K

-73.5%

Accounts Receivable

$5.13M

-48.8%

Inventory

$13.99M

+225.6%

Long Term Debt

$144.00K

-86.3%

Short Term Debt

$538.00K

-64.7%

Return on Assets

-44.00%

N/A

Return on Invested Capital

-42.85%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

-$15.45M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TLSITriSalus Life Sciences, Inc.
$4.67-0.74%
OSUROraSure Technologies, Inc.
$3.25+0.62%
PROFProfound Medical Corp.
$5.97+0.17%
STIMNeuronetics, Inc.
$3.03+0.66%

Trending Stocks

Symbol / CompanyPricePrice Chg
KHCKraft Heinz
$24.60+0.01%
ACVAACV Auctions
$10.41+0.44%
TNONTenon Medical
$5.93+0.12%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.16+0.03%

Questions About PRE

What is the current price of Prenetics Global?

Prenetics Global is trading at $23.47 per share.

What is the 52-week range for Prenetics Global?

Over the past 52 weeks, Prenetics Global has traded between $9.28 and $27.24.

How much debt does Prenetics Global have?

As of the most recent reporting period, Prenetics Global reported total debt of $682.00K.

How much cash does Prenetics Global have on hand?

Prenetics Global reported $59.05M in cash and cash equivalents in its most recent financial results.

What is Prenetics Global’s dividend yield?

Prenetics Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services